Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT03323567

A Comparison of Collagen, Lidocaine and Saline, in Trigger Points in Masseter Muscle.

A Comparison of Collagen, Lidocaine and Saline Intramuscular Injections, in Myofascial Pain Patients With Trigger Points in Masseter Muscle.

Sponsor: Medical University of Silesia

Conditions Temporomandibular Disorder

Interventions Lidocaine 2% Injectable Solution MD Muscle GUNA collagen Saline Solution, Hypertonic

Updated 5 times since 2017 Last updated: Jan 2, 2018 Started: Jan 10, 2016 Primary completion: Oct 4, 2017 Completion: Oct 12, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03323567, this EARLY_PHASE1 trial focuses on Temporomandibular Disorder and remains completed. Sponsored by Medical University of Silesia, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Nov 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Silesia

Data source: Medical University of Silesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zabrze, Poland